Led by Dr. Kathleen Mahoney in collaboration with Dr. Rupal Bhatt, both clinicians and scientists, and Dr. Gordon Freeman, a virologist and immunologist who contributed critical work to the discovery of the PD-1/PD-L1 pathway, this research team from the Dana-Farber Cancer Institute and Beth Israel-Deaconess Medical Center in Boston, Massachusetts received a 2019 Advanced Discovery Award.
Dr. Akash Kaushik is a postdoctoral researcher at the Children’s Medical Center Research Institute at UT Southwestern where he studies cancer cell metabolism, which includes all the processes that help cells take up nutrients and convert them to energy and other materials for growth.
Dr. Scott Haake is a medical oncologist and PhD candidate in cancer biology at Vanderbilt University Medical Center.
Daniele, who lives in Milano, Italy, was diagnosed with stage II kidney cancer at age 46 in 2005. However, Daniele never let his diagnosis get in the way of how he lived life.
Allen was diagnosed with stage IV clear cell renal cell carcinoma six years ago. After his diagnosis, he tried targeted therapy but experienced harsh side effects which eventually led him to having surgery.
Eric, who was otherwise a healthy individual, was diagnosed with stage II kidney cancer last December. The doctors estimated that the tumor had been growing for 9-10 years. Eric beat the cancer by undergoing a radical renal nephrectomy on his right kidney.